Soligenix, Inc. SEC filings SNGX

Soligenix, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Dec 3, 2008. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 21, 2026 (bylaw or fiscal year change, shareholder vote results, other events). The company's fiscal year ends on December 31.

Soligenix, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 2, 2026 —
4 Insider transaction Oct 13, 2026 Oct 12, 2026
4 Insider transaction Oct 13, 2026 Oct 12, 2026
4 Insider transaction Oct 13, 2026 Oct 12, 2026
4 Insider transaction Oct 13, 2026 Oct 12, 2026
4 Insider transaction Oct 13, 2026 Oct 12, 2026
4 Insider transaction Oct 13, 2026 Oct 12, 2026
4 Insider transaction Oct 13, 2026 Oct 12, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
Sep 21, 2026 Sep 17, 2026
4 Insider transaction Sep 18, 2026 Sep 17, 2026
4 Insider transaction Sep 18, 2026 Sep 17, 2026
4 Insider transaction Sep 18, 2026 Sep 17, 2026
4 Insider transaction Sep 18, 2026 Sep 17, 2026
424B3 Prospectus Aug 7, 2026 —
424B3 Prospectus Aug 7, 2026 —
424B3 Prospectus Aug 7, 2026 —
424B3 Prospectus Aug 7, 2026 —
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
ARS Annual report to shareholders Aug 3, 2026 Dec 31, 2025
DEFA14A Additional proxy material Aug 3, 2026 —
DEF 14A Proxy statement Aug 3, 2026 Sep 17, 2026
PRER14A Form- prer14a Jul 23, 2026 —
PRE 14A Preliminary proxy statement Jul 21, 2026 Sep 17, 2026
8-K Current report
Other events
Jun 26, 2026 Jun 26, 2026
424B5 Prospectus supplement Jun 26, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jun 25, 2026 —
8-K Current report
Listing notice, Officer or director change, Other events
Jun 12, 2026 Jun 10, 2026
8-K Current report
Other events
May 28, 2026 May 28, 2026
424B5 Prospectus supplement May 28, 2026 —
424B3 Prospectus May 8, 2026 —
424B3 Prospectus May 8, 2026 —
424B3 Prospectus May 8, 2026 —
424B3 Prospectus May 8, 2026 —
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Other events
Apr 28, 2026 Apr 28, 2026
EFFECT Filing Apr 2, 2026 —
EFFECT Filing Apr 2, 2026 —
EFFECT Filing Apr 2, 2026 —
EFFECT Filing Apr 2, 2026 —
POS AM Filing Mar 31, 2026 —
POS AM Filing Mar 31, 2026 —
POS AM Filing Mar 31, 2026 —
POS AM Filing Mar 31, 2026 —
10-K Annual report Mar 31, 2026 Dec 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Other events
Feb 12, 2026 Feb 12, 2026
424B5 Prospectus supplement Jan 23, 2026 —
8-K Current report
Other events
Jan 23, 2026 Jan 23, 2026
4 Insider transaction Dec 12, 2025 Dec 11, 2025
4 Insider transaction Dec 12, 2025 Dec 11, 2025
4 Insider transaction Dec 12, 2025 Dec 11, 2025
4 Insider transaction Dec 12, 2025 Dec 11, 2025
8-K Current report
Listing notice
Nov 18, 2025 Nov 18, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
424B3 Prospectus Nov 7, 2025 —
424B3 Prospectus Nov 7, 2025 —
424B3 Prospectus Nov 7, 2025 —
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
4 Insider transaction Oct 3, 2025 Oct 2, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 1, 2025 —
8-K Current report
Material agreement, Other events
Sep 29, 2025 Sep 25, 2025
424B4 Prospectus Sep 26, 2025 —
EFFECT Filing Sep 25, 2025 —
CORRESP Letter to the SEC Sep 23, 2025 —
CORRESP Letter to the SEC Sep 23, 2025 —
S-1 Registration statement Sep 19, 2025 —
UPLOAD Letter from the SEC Sep 2, 2025 —
DRS Filing Aug 27, 2025 —
8-K Current report
Other events
Aug 18, 2025 Aug 18, 2025
424B3 Prospectus Aug 15, 2025 —
8-K Current report
Listing notice
Aug 15, 2025 Aug 15, 2025
424B3 Prospectus Aug 15, 2025 —
424B3 Prospectus Aug 15, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Other events
Jul 31, 2025 Jul 31, 2025
4 Insider transaction Jun 20, 2025 Jun 20, 2025
4 Insider transaction Jun 20, 2025 Jun 20, 2025
4 Insider transaction Jun 20, 2025 Jun 20, 2025
4 Insider transaction Jun 20, 2025 Jun 20, 2025
S-8 Employee stock plan registration Jun 20, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 20, 2025 Jun 20, 2025
10-Q Quarterly report May 9, 2025 Mar 31, 2025
ARS Annual report to shareholders May 5, 2025 Dec 31, 2024
DEFA14A Additional proxy material May 5, 2025 —
DEF 14A Proxy statement May 5, 2025 Jun 20, 2025
8-K Current report
Bylaw or fiscal year change
Mar 28, 2025 Mar 25, 2025
EFFECT Filing Mar 26, 2025 —
EFFECT Filing Mar 26, 2025 —
EFFECT Filing Mar 26, 2025 —
POS AM Filing Mar 21, 2025 —
POS AM Filing Mar 21, 2025 —
POS AM Filing Mar 21, 2025 —
10-K Annual report Mar 21, 2025 Dec 31, 2024
8-K Current report
Agreement ended
Feb 10, 2025 Feb 5, 2025
4 Insider transaction Dec 13, 2024 Dec 12, 2024
4 Insider transaction Dec 13, 2024 Dec 12, 2024
4 Insider transaction Dec 13, 2024 Dec 12, 2024
4 Insider transaction Dec 13, 2024 Dec 12, 2024
4 Insider transaction Dec 13, 2024 Dec 12, 2024
4 Insider transaction Dec 13, 2024 Dec 12, 2024
4 Insider transaction Dec 13, 2024 Dec 12, 2024
4 Insider transaction Dec 13, 2024 Dec 12, 2024
424B3 Prospectus Nov 8, 2024 —
424B3 Prospectus Nov 8, 2024 —
424B3 Prospectus Nov 8, 2024 —
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Material agreement, New debt
Oct 11, 2024 Oct 8, 2024
424B5 Prospectus supplement Aug 16, 2024 —
8-K Current report
Other events
Aug 16, 2024 Aug 16, 2024
424B3 Prospectus Aug 9, 2024 —
424B3 Prospectus Aug 9, 2024 —
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
EFFECT Filing Aug 2, 2024 —
CORRESP Letter to the SEC Jul 30, 2024 —
UPLOAD Letter from the SEC Jul 29, 2024 —
8-K Current report
Material agreement
Jul 25, 2024 Jul 24, 2024
S-1 Registration statement Jul 24, 2024 —
8-K Current report
Material agreement, Unregistered share sale
Jul 9, 2024 Jul 9, 2024
8-K Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
May 31, 2024 May 30, 2024
DEFA14A Additional proxy material May 29, 2024 —
DEFA14A Additional proxy material May 28, 2024 —
8-K Current report
Shareholder vote results, Regulation FD disclosure
May 24, 2024 May 23, 2024
DEFA14A Additional proxy material May 22, 2024 —
8-K Current report
Other events
May 17, 2024 May 17, 2024
DEFA14A Additional proxy material May 17, 2024 —
DEFA14A Additional proxy material May 15, 2024 —
424B3 Prospectus May 10, 2024 —
10-Q Quarterly report May 10, 2024 Mar 31, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 29, 2024 May 23, 2024
8-K Current report
Material agreement, Other events
Apr 22, 2024 Apr 17, 2024
PRE 14A Preliminary proxy statement Apr 19, 2024 May 23, 2024
424B4 Prospectus Apr 19, 2024 —
EFFECT Filing Apr 15, 2024 —
CORRESP Letter to the SEC Apr 15, 2024 —
CORRESP Letter to the SEC Apr 15, 2024 —
CORRESP Letter to the SEC Apr 3, 2024 —
8-K Current report
Other events
Apr 3, 2024 Apr 3, 2024
CORRESP Letter to the SEC Apr 2, 2024 —
CORRESP Letter to the SEC Apr 2, 2024 —
S-1/A Amended registration statement Apr 2, 2024 —
S-1/A Amended registration statement Mar 15, 2024 —
10-K Annual report Mar 15, 2024 Dec 31, 2023
UPLOAD Letter from the SEC Jan 19, 2024 —
S-1 Registration statement Jan 16, 2024 —
8-K Current report
Listing notice
Dec 22, 2023 Dec 21, 2023
EFFECT Filing Dec 15, 2023 —
4 Insider transaction Dec 15, 2023 Dec 15, 2023
4 Insider transaction Dec 15, 2023 Dec 15, 2023
4 Insider transaction Dec 15, 2023 Dec 15, 2023
4 Insider transaction Dec 15, 2023 Dec 15, 2023
8-K Current report
Shareholder vote results
Dec 15, 2023 Dec 15, 2023
CORRESP Letter to the SEC Dec 14, 2023 —
4 Insider transaction Dec 8, 2023 Dec 8, 2023
4 Insider transaction Dec 8, 2023 Dec 8, 2023
4 Insider transaction Dec 8, 2023 Dec 8, 2023
4 Insider transaction Dec 8, 2023 Dec 8, 2023
S-3/A Filing Dec 8, 2023 —
CORRESP Letter to the SEC Dec 6, 2023 —
CORRESP Letter to the SEC Nov 30, 2023 —
8-K Current report
Shareholder vote results, Regulation FD disclosure
Nov 17, 2023 Nov 16, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Shareholder vote results, Regulation FD disclosure
Oct 20, 2023 Oct 18, 2023
DEFA14A Additional proxy material Oct 17, 2023 —
DEFA14A Additional proxy material Oct 17, 2023 —
DEFA14A Additional proxy material Oct 16, 2023 —
DEFA14A Additional proxy material Oct 13, 2023 —
DEFA14A Additional proxy material Oct 12, 2023 —
DEFA14A Additional proxy material Oct 12, 2023 —
DEFA14A Additional proxy material Sep 22, 2023 —
8-K Current report
Shareholder vote results, Regulation FD disclosure
Sep 22, 2023 Sep 21, 2023
DEFA14A Additional proxy material Sep 15, 2023 —
8-K Current report
Auditor change, Other events
Sep 15, 2023 Sep 15, 2023
UPLOAD Letter from the SEC Sep 12, 2023 —
S-3 Shelf registration Aug 30, 2023 —
10-Q Quarterly report Aug 21, 2023 Jun 30, 2023
NT 10-Q Filing Aug 14, 2023 Jun 30, 2023
ARS Annual report to shareholders Aug 7, 2023 Dec 31, 2022
DEFA14A Additional proxy material Aug 7, 2023 —
DEF 14A Proxy statement Aug 7, 2023 Sep 21, 2023
8-K Current report
Officer or director change
Jul 7, 2023 Jul 7, 2023
8-K Current report
Listing notice
Jun 23, 2023 Jun 23, 2023
8-K Current report
Listing notice
May 26, 2023 May 23, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Material agreement, Other events
May 9, 2023 May 5, 2023
424B4 Prospectus May 8, 2023 —
EFFECT Filing May 5, 2023 —
4 Insider transaction May 5, 2023 May 3, 2023
3 Initial insider ownership May 5, 2023 May 3, 2023
CORRESP Letter to the SEC May 4, 2023 —
S-1/A Amended registration statement May 4, 2023 —
8-K Current report
Material agreement, Officer or director change
May 3, 2023 May 3, 2023
8-K Current report
Other events
May 1, 2023 May 1, 2023
S-1/A Amended registration statement Apr 20, 2023 —
CORRESP Letter to the SEC Apr 19, 2023 —
8-K Current report
Material agreement, New debt
Apr 19, 2023 Apr 19, 2023
8-K Current report
Other events
Apr 14, 2023 Apr 14, 2023
8-K Current report
Listing notice
Apr 10, 2023 Apr 6, 2023
UPLOAD Letter from the SEC Apr 7, 2023 —
S-1 Registration statement Mar 31, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SNGX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Princeton, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
812796
Former names
SOLIGENIX, INC. (until Nov 2, 2026); DOR BIOPHARMA INC (until Sep 29, 2009); ENDOREX CORP (until Oct 24, 2001); IMMUNOTHERAPEUTICS INC (until Apr 30, 1996)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.